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ABSTRACT  We studied plasminogen activator (PA) of the rat pituitary gland in organ and cell 
monolayer  culture.  Both anterior  and intermediate  lobes contain,  synthesize and secrete a 
mixture  consisting of the two known  types of PA: urokinase and so-called tissue PA. Both 
enzymes were formed essentially by all PA secreting cells, and PA was identified  specifically 
in mammotrophs, corticotrophs,  and luteinizing hormone containing gonadotrophs. 
Pituitary  PA production was  modulated  on exposure to a variety  of biological  effectors: 
anterior lobe PA secretion was stimulated by agents that raised intracellular cAMP concentra- 
tion; this process depended on de novo enzyme synthesis. Enzyme production was repressed 
by androgens and glucocorticoids.  When anterior lobe cultures were maintained in plasmin- 
ogen-free media, the extracellular, secreted forms of ACTH consisted almost exclusively of 
the high molecular weight forms (31,000 and 23,000); the smaller forms (13,000 and 4,500) 
were also found in the extracellular medium of cultures supplemented with plasminogen. In 
contrast, the size distribution  of intracellular ACTH species was unaffected by the presence 
of plasminogen. These results resemble those previously obtained with pancreatic islets and 
are consistent with  the possibility  that plasmin, generated by  PA secretion, participates in 
prohormone  processing. 
PA synthesis in intermediate  lobe explants was stimulated by exposure to dibutyryl cAMP, 
and repressed by hydrocortisone. In accordance with the dopaminergic control of intermediate 
lobe function in some vertebrates, apomorphine  strongly repressed PA synthesis in interme- 
diate, but not anterior lobe cultures. 
A growing body of evidence indicates that plasminogen acti- 
vator (PA) 1 production is a pervasive cellular mechanism for 
initiating localized proteolysis (33). This process is common 
to a broad spectrum of cell types, is correlated with a variety 
of physiological phenomena and, in most cases, is modulated 
by specific hormones. PA is particularly conspicuous in en- 
docrine tissue including the thyroid (J.-D.  Vassalli,  unpub- 
lished observations),  parathyroid (5), and pancreatic islets; in 
the latter, the rate of PA synthesis is determined by extracel- 
lular glucose concentration and enzyme production may pro- 
vide a mechanism for prohormone processing (46). 
Recent studies of adrenocorticotropin (ACTH)  structure 
and synthesis in amphibian (8, 22) and mammalian pituitary 
(9, 26,  35) have shown that the predominant 4,500-mol-wt 
form of corticotropin is derived from a larger (31,000 mol wt) 
~Abbreviations  used  in  this  paper.  ACTH, adrenocorticotropin; 
dbcAMP, dibutyryl cyclic AMP; LH, luteinizing  hormone; a-MSH, 
c~-melanotropic-stimulating  hormone; PA, plasminogen  activator. 
precursor that carries  the  antigenic determinants for both 
ACTH and B-lipotropin: corticotropin is apparently generated 
by proteolytic processing  at sites consisting of two adjacent 
positively charged amino acids.  Such sites  are common to 
many proteins, including the prohormones for insulin (4, 38), 
ACTH (27), and parathyroid hormone (15) among others (18, 
34), and indicate that processing is probably catalyzed by an 
enzyme with trypsin-like specificity. This inference is strength- 
ened by the finding that brief trypsinization can convert both 
proinsulin (38) and "big" ACTH to the respective hormonal 
derivatives (12); however, trypsin itself cannot normally me- 
diate prohormone conversion since it is produced only in the 
exocrine pancreas, and another enzyme must therefore be 
responsible for hormone processing. 
A number of considerations prompted us to examine PA 
production in the pituitary gland: firstly, as already noted, PA 
is  synthesized abundantly in  other endocrines that secrete 
peptide hormones, but not in the adrenal cortex where only 
steroid hormones are produced (M. McConnell and E. Reich, 
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produces several peptide hormones, and it appeared of  interest 
to determine which, if any, of the corresponding specific cell 
types produced PA. Thirdly, hormone formation in the pitui- 
tary can be modulated by a variety of effector molecules that 
also influence PA production in other tissues, and it seemed 
worthwhile to establish whether pituitary PA and hormone 
syntheses were coordinated in any way.  Finally plasmin,  a 
trypsin-like enzyme that is generated by plasminogen activa- 
tor,  has  been  shown  to  convert proinsulin  to  a  molecule 
electrophoretically indistinguishable from insulin (46);  thus 
the possibility that plasmin might participate, by analogy, in 
the processing of ACTH precursors invited exploration. 
MATERIALS AND  METHODS 
Female Sprague Dawley rats weighing 150-200 g were purchased from Charles 
River Breeding Laboratories, Inc., (Wilmington, MA). [aSS]Methionine  (specific 
activity 1,000 Ci/mM) was obtained  from Schwarz/Mann  Div., Becton, Dick- 
inson  & Co.  (Orangeburg,  NY).  Dulbecco's  minimal  essential medium and 
fetal bovine serum were from Grand Island Biological Co. (Grand Island, NY); 
hydrocortisone,  cholera  toxin,  2-dibutyryl  cAMP  (dbcAMP),  apomorphine, 
Trasylol, phenylmethylsulphonyl fluoride, and iodoacetamide were from Sigma 
Chemical Co. (St. Louis, MO); urokinase  reference standard  from Leo Phar- 
maceutical Products (Ballerup, Denmark);  casein (as milk powder) was from 
Carnation; tissue culture plasticware was obtained  from Falcon Labware (Ox- 
nard,  CA); a-melanotropic-stimulating  hormone (a-MSH),  hiteinizing-hor- 
mone-releasing hormone and tyrotropic-releasing hormone were from Bachem 
Co. (Torrance, CA). All the other reagents were of the highest grade commer- 
cially available. 
Preparation of Pituitary Cultures 
A N T E R I O R  L O B E:  Cells were prepared  from  the pituitaries  of Sprague- 
Dawley female rats, weighing 150-200 g, by a trypsin digestion technique (l 7). 
After decapitation,  the pituitary glands were removed from the skull and the 
anterior lobes were trimmed free of other tissue and minced with scalpels. The 
minced tissue was incubated  under agitation  at 37"C for 2 h in Dulbecco's 
medium containing  l  mg/ml bovine  serum albumin and  l  mg/ml trypsin 
(Worthington  Biomedical Co., Freehold, N  J) At the end of this treatment,  the 
cells and small pieces of tissue were collected by centrifugation,  washed twice 
with medium containing antibiotics and 10% plasminogen depleted fetal bovine 
serum (30) and resuspended in fresh medium. The suspension was then passed 
twice through a 20 gauge hypodermic needle to facilitate dispersion of  the ceils. 
After a final wash, the cells were plated in 0.5 ml of the above medium at the 
desired densities (usually  l  x  l0  s ceils/well) in Linbro  wells (FB  16-24 TC; 
Linbro Scientific, Hamden,  CT). The recovery of viable cells was usually 5 x 
l0  s per pituitary. Following incubation  for 48 h, the medium was removed, the 
cultures were washed twice with phosphate  buffer and then incubated  with 
serum free medium plus or minus the effectors to be tested;  8 h  later the 
medium  was again changed and fresh serum free medium (250  ul) supple- 
mented with the effectors was added. Conditioned  medium was then harvested 
at the desired time intervals, usually  16-18  h, and assayed. Cells were also 
collected, washed in phosphate buffer, and lysed in 0.1% Triton X-100. 
INTERMEDIATE  LOBE:  The  pars nervosa  and  pars intermedia  were 
carefully separated  from the pars distalis, sectioned longitudinally,  and both 
halves were placed onto lens paper floating on culture medium. The lens papers 
were incubated at 37"C in individual wells of multiwell plates with 0.3 ml of 
serum free medium, supplemented with effectors and exposed to an atmosphere 
of 95%  02/5%  CO2 saturated  with  water  vapor.  After  24--48 h, the  organ 
cultures were transferred to a ~251-fibrin plate containing  300/zl of medium,  l0 
gg/ml of purified human plasminogen was added and the fibrinolytic activity 
was determined.  To determine  the protein content,  the explants were washed 
three times with cold phosphate buffer and dissolved in 0. I N NaOH for 30 h. 
ASSAY OF  PLASMINOGEN  ACTIVATOR:  All assays were performed in 
triplicate and all  values are  given as the mean of the  three  determinations. 
Multiwell plates coated with t25I-fibrin were prepared as previously described 
(40); each well contained  10 ug of fibrinogen (I x  105 cpm/well). Aliquots of 
incubation  media and cell lysates were assayed in 250 ul of 0.1  M Tris HCI, 
pH  8.1, containing  2 ug purified  human plasminogen  (6). All  experiments 
included appropriate  controls for reagents and media. Plasminogen independ- 
ent proteolysis was monitored  by performing parallel assays in the absence of 
plasminogen; such plasminogen independent  proteolysis never exceeded 1% of 
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the  total  activity.  The  PA  content  of incubation  media  and  cell lysates is 
expressed in Ploug units, as determined with reference to a standard preparation 
of urokinase  (urokinase  reference  standard;  Leo  Pharmaceutical  Products, 
Ballerup, Denmark). 
PA  production  by individual  cells was assayed by  a  casein/agar  overlay 
procedure  (44): cells plated  in  Falcon  60  mm tissue-culture  dishes (Falcon 
Labware) were overlaid with a casein/agar mixture containing plasminogen (40 
#g/ml). Development  of caseinolytic plaques was observed by dark field illu- 
mination. 
Detection  of plasminogen  activator  following SDS PAGE  was performed 
according  to  Granelli-Piperno  and  Reich  (13). To  immunoprecipitate  the 
enzyme conditioned  medium (containing the equivalent of 40-80 mU uroki- 
nase) was first incubated for 16 h at 4"C with either antiurokinase  lg (60 gg) or 
anti-tissue activator Ig (50 gg); protein A sepharose was then added for 30 min 
at 22"C to precipitate the enzyme-lg complexes from which enzyme was eluted 
in 1% SDS solution. 
ANTIBODY PRODUCTION:  Antibodies to ACTH were raised in rabbits 
injected weekly with  1 mg/ml of human ACTH (1-39)  (generously provided 
by Organon) for 3 wk. Antibodies to prolactin and luteinizing hormone (LH) 
were raised in mice injected with 50 ag of highly purified antigens (generous 
gift of Dr. D. Burleigh [ICN Pharmaceuticals,  Inc.l). The animals were boosted 
after 3 wk with  10 ~g of antigen and antisera were collected after 4 d. Anti- 
urokinase antibodies  were supplied by Dr. D. Belin and anti-tissue activator 
antibodies were from Dr. W.-D. Schleuning of this laboratory. 
IMMUNOFLUORESCENCE:  Cells  were  fixed for  10  min  in  absolute 
methanol,  washed twice with phosphate  buffer, pH 7.4, and incubated  with 
diluted antisera (usually l:10) at 37°C for 30 rain. After three  10-min washes, 
the first at 37"C and the last two at room temperature,  fluorescein conjugated 
goat anti-rabbit and anti-mouse  lgG (diluted  1:100) were added, and a second 
sequence of incubation  and washing was repeated as above. 
INCUBATION  OF  ANTERIOR LOBE CELLS WITH  RADIOACTIVE 
AMINO ACIDS:  I X  l& anterior  lobe cells were plated in 35-ram  Falcon 
tissue culture dishes for 48 h in Dulbecco's medium supplemented  with 10% 
fetal calf serum or plasminogen-depleted fetal calf serum. The cells were then 
labeled for 10 h with 200 t~Ci/ml of [3SS]methioninc (Amersham-Searle, Ar- 
lington Heights, IL; 1,000 ci/mmol),  in methionine-deficient  medium supple- 
mented  with  appropriate  serum.  The  medium was harvested,  the protease 
inhibitors  phenylmethylsulphonyl  fluoride,  iodoacetamide,  pepstatin  (1  mM 
each), Trasyiol (100 U/ml) were added, the medium was centrifuged to remove 
cell debris, and ACTH was immunoprecipitated.  To examine the intracellular 
compartment, we extracted cells in 5 N acetic acid containing  5 mg/ml BSA 
and the above protease inhibitors. The extracts were frozen and thawed three 
times, incubated  at 4"C overnight, centrifuged to remove  insoluble material, 
and lyophilized. 
ACTH IMMUNOPRECIPITATION:  ACTH antiserum was purified  by 
affinity chromatography  using a sepbarose-ACTH (1-24) column as described 
by Mains and Eipper (24). Immunoprecipitation  was carried out as follows." 
briefly, culture medium and lyophilized samples (resuspended in 50 mM Tris- 
HC1, pH 7.4) were made  1% in SDS, boiled for 5 min, after which Triton X- 
I00 was added to a final concentration  of 5%. The samples were immunopre- 
cipitated for 16 h at 4°C, protein A Sepharose was added, the mixture incubated 
for 30 rain at room temperature  and then centrifuged. The pellets were washed 
three times with NETTS buffer (0.5 M NaCI, 0.2% SDS, 1% Triton  X-100,  1 
mM EDTA, 50 mM Tris-HCl, pH 7.4) and once with 0.5 M NaCI, 0.1% SDS, 
50 mM Tris-HCl, H 7.4. Proteins were eluted by boiling the pellets in electro- 
phoresis sample  buffer.  Samples were anal.y..~d by electrophoresis  in  12.5% 
SDS polyacrylamide gels according to Laemmli  (19), using molecular  weight 
markers from Pharmacia  Fine Chemicals (Piseataway, N  J). After electropho- 
resis the individual lanes of the gel were cut into 2-mm slices, dissolved in 20% 
H202 for 16 h at 45"C, mixed with Aquasol, and radioactivity determined in a 
scintillation counter. Proteins were determined using a Bio-Rad assay (Bio-Rad 
Laboratories, Richmond,  CA) developed by Bradford (3). 
RESULTS 
Anterior Lobe 
PRODUCTION  AND  SECRETION  OF  PA;  CHARACTER- 
IZATION OF PITUITARY PA:  In view of the structural and 
functional complexity of  the pituitary, we used separated lobes 
rather than intact glands as starting material for assessing PA 
production either in organ culture or, after suitable dispersion 
to single cell suspensions, in monolayer culture. As seen in 
Fig. l, secretion is maintained in primary monolayer cultures 
for at least 7 d, during which enzyme activity in the condi- tioned  medium  continues to  increase.  This  accumulation 
represents de novo synthesis and not merely release of pre- 
formed intracellular stores,  since  the  appearance  of PA  is 
blocked by inhibitors of genetic transcription (actinomycin 3 
~g/ml) or translation (cycloheximide 5 #g/ml). Similar results 
have been  obtained  using  anterior lobe explants  in  organ 
culture using the method of Ossowski et al. (29). 
Two discrete and catalytically efficient plasminogen acti- 
vators are  known  to  be  produced by mammalian  tissues, 
namely, urokinase and the so-called tissue PA, and both of 
these were identified in  gland  extracts and  in  conditioned 
media from monolayer cultures. The results of zymographic 
assays (Fig. 2A) show the presence of  two major PA activities 
whose electrophoretic mobilities correspond to apparent mo- 
lecular weights of 80,000 and 48,000, respectively. The activ- 
ity of the  slower-migrating component was  selectively and 
completely blocked by rabbit antisera raised against  highly 
purified, homogeneous human tissue PA,  and was  thereby 
identified as the homologous rat enzyme (Fig. 2 B). The more 
rapidly migrating 48,000-mol-wt enzyme was identified as rat 
urokinase by two criteria: its mobility was identical with that 
of the predominant  PA  species  in  rat  urine,  and  catalytic 
activity was completely blocked by purified immunoglobulins 
from antisera to pure mouse urokinase (Fig.  2B). As in all 
other known mammalian preparations, both enzymes were 
irreversibly inactivated by exposure to diisopropylfluorophos- 
phate (1 mM, 40"C, 24 h). The synthesis of both forms of PA 
was also modulated in response to hormonal effectors. 
IDENTIFICATION  OF  PA-PRODUCING  PITUITARY 
CELLS:  The cellular composition of  the anterior lobe is com- 
plex, reflecting the large number of different hormones pro- 
duced in this portion of  the gland. PA production in the other 
normal tissues so far analyzed has always been correlated with 
specific physiological processes or responses, and it was there- 
fore of interest to determine whether pituitary PA  activity 
could be assigned to one or more of the known cell types. To 
this end, monolayer cultures containing widely dispersed cells 
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FIGURE  1  Plasminogen  activator production by anterior pituitary 
cells as a function of time in culture. Pituitary cells were plated at a 
density of 1 x  10  s cells/well. After 48 h the cultures were washed 
and 250 ~1 of medium containing 10% plasminogen depleted acid- 
treated fetal bovine serum were added to each well. The medium 
was collected at 24-h intervals and cells from three wells were lysed 
in 250/~1 of 0.1% Triton X-100. Aliquots of culture medium (20 ~1) 
and cell lysate (5/.d)  were assayed for plasminogen activator. The 
results for both intracellular and extracellular  enzyme are expressed 
as mU urokinase per 1 x  10  s cells  (three cultures per group). O, 
conditioned medium {accumulated activity at the indicated time); 
O, cell lysate. 
FIGURE  2  (A) Plasminogen  activators of anterior and intermediate 
lobes of rat pituitary. Zymographic analysis of conditioned media 
and cell lysates was performed exactly as described in reference 9. 
The samples were applied to an 11% SDS polyacrylamide slab gel. 
After electrophoresis, SDS was extracted, the slab was applied to 
fibrin-agar indicator gel containing plasminogen, incubating for 12 
h at 37°C, and the indicator gel fixed and stained. No lytic zones 
were observed in the absence of plasminogen. Lane 1: Cell lysate 
from 5 x  104 anterior lobe cells. Lane 2: Conditioned medium from 
5 x  104 anterior lobe cells.  Lane 3: Cell lysate from three interme- 
diate lobes. Lane 4: Conditioned medium from three intermediate 
lobes. (B) Identification of plasminogen activators of anterior lobe 
cultures after immunoprecipitation with anti-urokinase or anti-tis- 
sue  activator antibodies. Aliquots  of conditioned medium were 
immunoprecipitated as described in  Materials and Methods. The 
immunoprecipitates were applied to an  11% SDS  polyacrylamide 
slab gel. After electrophoresis  the gel was analyzed for plasminogen 
activators by  layering onto  a  plasminogen containing fibrin-agar 
indicator gel. Lane  1: Control conditioned medium before immu- 
noprecipitation. Lane 2: Immunoprecipitate  with anti-urokinase Ig. 
Lane 3:  Immunoprecipitate with anti-tissue activator Ig. (C) Identi- 
fication of  plasminogen activators of anterior lobe cultures after 
treatment with cAMP or hydrocortisone. Aliquots of conditioned 
media and cell extracts were analyzed on an  11% SDS  polyacryl- 
amide slab  gel.  After  electrophoresis the  gel  was  analyzed for 
plasminogen  activators by layering  in onto a plasminogen  containing 
fibrinagar  indicator  gel.  A,  a:  Conditioned  medium  and  lysate, 
respectively, from control cultures. B,  b: the same from hydrocor- 
tisone  treated  (10  -7  M)  cultures.  C,  c:  the  same  from  cultures 
exposed to cAMP (10  -3 M). 
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tion using an agar overlay procedure in which enzyme secre- 
tion is easily detected by the appearance of surrounding clear 
lytic zones (44).  After incubation  for a  period  sufficient to 
generate distinct  lytic zones,  the  culture  was fixed, the  PA 
producing zones were marked, the agar overlay was removed, 
and the cells in separate cultures were then characterized by 
immunofluorescence  using  monospecific antisera  directed, 
respectively, against prolactin, LH, and corticotropin (see Fig. 
3). From the results in Table I, it can be seen that (a) in all 
cultures, ~35-40% of anterior lobe cells were PA producing; 
(b) PA production was detected in each of the specific popu- 
lations that were examined: approximately one third of the 
mammotrophs and gonadotrophs, and about one fifth of the 
corticotrophs were PA secreting cells.  Thus enzyme produc- 
tion  was not  limited either to a  single,  or to a  minor sub- 
population of anterior lobe cells.  Because both kinds of PA 
were observed in zymographic assays of conditioned media, 
an experiment identical with that in Table I was performed 
to determine the distribution of cells producing the urokinase 
and  tissue  activator  forms of PA.  In  this  case,  lytic  zone 
production was monitored as usual, but with the agar overlay 
containing Ig directed against urokinase, tissue activator, both 
enzymes, or neither.  The  results were that  each  IgG alone 
reduced  the  diameter,  but  not  the  number of lyric zones, 
whereas the presence of both antibodies eliminated all lytic 
plaques.  It  follows that  most,  and  probably all  of the  PA 
producing anterior lobe cells are secreting a  mixture of the 
two PA enzymes. 
MODULATION  OF  ANTERIOR  LOBE  PA  PRODUC- 
TION:  There are  several  reasons why it  was of interest  to 
study the  modulation  of pituitary PA  synthesis:  firstly,  PA 
production in  virtually all nonneoplastic cells  is modulated 
by a variety of hormones and hormone-like agents, and it was 
therefore desirable to  compare the  previously documented 
patterns of PA modulation with that of the pituitary, itself a 
distinctly hormone-responsive tissue.  Secondly, the anterior 
pituitary, like the endocrine pancreas,  is  specialized for the 
production of polypeptide hormones, and PA production in 
the  islets  of Langerhans is closely correlated with 0-cell re- 
sponses  to  glucose  and  other  effectors that  are  known  to 
modulate  insulin  production  (46).  Hence,  it  seemed worth 
exploring the extent to which the regulatory patterns of pitui- 
tary PA synthesis resembled that of the pancreatic islets. 
It is well established from the work of several laboratories 
that  some  pituitary  hormone  production  is  modulated  by 
changes in  intracellular cAMP concentrations (23,  31),  and 
the data in Fig. 4 show that pituitary PA secretion is strongly 
stimulated by the addition ofdbcAMP to the culture medium. 
The  cAMP  phosphodiesterase  inhibitor  l-methyl-3-isobu- 
tylxanthine produced a similar effect, as did cholera toxin, an 
agent that  stimulates adenyl cyclase activity; its action was 
maximal at the low concentration of 10-" M. The stimulation 
of PA  secretion  both  by  dbcAMP  and  cholera  toxin  was 
completely blocked in the presence of actinomycin (3 ~g/ml) 
TABLE  I 
Single Cell Assay for Plasminogen Activator and Hormone 
Production 
Antiserum  PA  +,  H-  PA  +,  H ÷  PA-,  H +  PA-,  H- 
Prolactin  23.7  15.0  28.4  32.9 
LH  29.9  10.7  19.2  40.0 
ACTH  33.3  1.8  8.4  56.7 
Anterior pituitary cells were plated at a density of 1 x  104 cells in 60-mm 
tissue culture dishes.  After 24-48  h the cultures were washed and overlaid 
with a casein-agar mixture containing plasminogen, incubated at 37°C for 5 
h  and then fixed (Materials and  Methods).  Lytic  zones were identified  by 
dark-field  microscopy,  marked, the casein-agar overlay was removed, and 
the plates washed twice with  phosphate buffer and processed for immuno- 
fluorescence. Separate, parallel cultures were analyzed using,  respectively 
antisera to prolactin,  LH,  and ACTH antisera. The results are expressed as 
the percent of cells that were positive for plasminogen activator and negative 
(not fluorescent) for the  hormone  production  (PA  +,  H-);  positive for both 
plasminogen activator and the hormone (PA  +, H+); negative for plasminogen 
activator  and  positive  for  the  hormone  (PA-,  H+);  or  negative  for  both 
plasminogen activator and the hormone (PA-,  H-). The values given are the 
means of four separate experiments. 
FIGURE  3  Single cell assay for plasminogen activator and hormone production. Anterior pituitary cells were plated at a density 
of 1 x  104 cells in 60mm tissue culture dishes. After 24-28 h, the cultures were washed and overlaid with a casein-agar mixture 
containing plasminogen, incubated at 37°C for 5 h and then fixed. Lytic zones were identified by dark-field microscopy, marked, 
the casein-agar overlay was removed, and the plates were processed for immunofluorescence using anti-prolactin antiserum. (A) 
Cell  surrounded  by  lytic area. (B) The  same cell  stained with  anti-prolactin. (Indirect  immunofluorescence was performed as 
described in Materials and Methods.) Approximately x  50. 
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quired genetic transcription and translation. The cyclic nu- 
cleotide mediated induction of PA secretion therefore repre- 
sents  do  novo synthesis,  and  not  simply the  discharge  of 
intracellular enzyme. 
The anterior lobe responds to a variety of  hormonal stimuli 
by changing polypeptide hormone production; hence, if PA 
synthesis was somehow coordinated with hormone formation, 
changes  in  enzyme production  might  also  be  induced by 
physiological regulators of pituitary function. As seen in Fig. 
5, hydrocortisone, which suppresses pituitary ACTH produc- 
tion, also progressively reduced PA synthesis throughout a 
physiological range of concentrations; the mineralocorticoid 
aldosterone was somewhat less effective. Likewise, the andro- 
gen testosterone repressed PA synthesis, but only at pharma- 
cological levels, whereas/~-estradiol and progesterone at phys- 
iological concentrations  showed  no  effect.  The  inhibitory 
actions of testosterone and hydrocortisone were additive, the 
two  steroids  together blocking enzyme production almost 
completely, an effect that presumably results from the two 
hormones acting on a mixture of different cell types. There 
are two further points of interest concerning the modulation 
of anterior lobe PA:  the first is that the inhibitory effect of 
hydrocortisone was dominant over that of cAMP, since cul- 
tures pretreated with glucocorticoid showed no stimulation 
of PA synthesis in response to dbcAMP. The second concerns 
the differential response of the two PA species to modulation: 
cAMP predominantly stimulated the production of the tissue 
activator form, whereas hydrocortisone repressed the synthe- 
sis of both (Fig. 2 C). 
We also  tested  the  effect of a  variety of agents  on  PA 
production--some of these are significant for pituitary phys- 
iology, whereas others had previously been shown to modulate 
enzyme synthesis by other cell types. In the concentration 
range 10 ng- l0 ~g/ml, the following compounds had no effect 
on  anterior lobe PA  production:  vasopressin,  epinephrine, 
apomorphine,  highly  purified  rat-follicle-stimulating  hor- 
mone, human ACTH, ovine prolactin, bovine insulin, syn- 
thetic a-MSH, tyrosine, and the hypothalamic releasing fac- 
tors luteinizing-hormone-releasing hormone and thyrotropic- 
releasing hormone. Also without effect were the same concen- 
trations of retinoids, concanavalin A, and phorbol ester, all 
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FIGURE  4  Effect of cyclic nucleotide and related compounds on 
plasminogen  activator production in anterior pituitary cultures: dose 
response curves. Anterior cells were plated at a density of 1 x  10  s 
cells per well and exposed to the various agents as described in 
Materials and  Methods.  Aliquots (20  /zl) of culture  media were 
assayed for PA and the results are expressed as mU urokinase in 
the medium per 1 x  105 cells. Each point represents the average of 
the values obtained from two parallel cultures. &, cholera toxin; O, 
dbcAMP; O, 1-methyl-3-isobutylxanthine. 
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FIGURE  5  Effect  of  steroids  on 
plasminogen  activator production 
in anterior pituitary cultures: dose 
response  curves.  Anterior  pitui- 
tary  cells  were  plated  (1  x  10  s 
cells per well) and exposed to the 
indicated steroids as described in 
Materials and Methods. Aliquots 
(20/~1) of conditioned media were 
assayed  for  PA  and  the  results 
expressed as  the  percentage of 
the enzyme level present in the 
medium of control, hormone-free 
cultures. The level of enzyme in 
conditioned  medium  from  con- 
trol cultures (100%)  was 55  mU 
urokinase/10  s  cells,  e,  aldoste- 
rone; &, hydrocortisone; ©, dihy- 
drotestosterone; A,  estradiol; n, 
progesterone. 
of which strongly induce PA production either in chick fibro- 
blasts and mouse teratoma cells (4 l, 47, 48), or macrophages 
and leukocytes, respectively (14, 45). 
FORMS  OF  ACTH  PRODUCED  BY  THE  ANTERIOR 
LOBE:  It is known that several forms of ACTH are normally 
present in the mammalian circulation (49, 50)--these include 
the predominant, small form of  M, 4,500, in addition to larger 
species of Mr 13,000 (a glycosylated version of the Mr 4,500 
species), Mr 23,000 and 31,000, the latter being considered as 
precursor molecules subject to proteolytic processing (9, 35). 
All of these molecular weight species are present within pitui- 
tary cells, but it has not been proven that the fully processed 
intracellular forms (i.e.,  4,500  and  13,000)  are released in 
response to physiological stimuli and are the precursors to the 
circulating extracellular forms. It is, however, also clear from 
studies of cultured pituitary tumor cell lines that intracellular 
corticotropin (4,500) is derived from a larger molecule (31,000 
mol wt) that carries antigenic determinants both for B-lipotro- 
pin and ACTH (9, 35). This same large precursor is secreted 
in substantial amounts by cultured pituitary cells (9), a finding 
that is in accord with similar observations on gastrin (49), LH 
(25), and insulin (37), where, in each case, the prohormone 
form accounts for a substantial fraction of the total secretion 
product. The fact that large precursors are secreted in all of 
these systems suggests that some prohormone conversion may 
occur extracellularly, a  possibility previously envisaged for 
insulin  production in  the  islets  of Langerhans (46).  These 
considerations  prompted  us  to  examine  the  spectrum  of 
ACTH molecules synthesized in the presence and absence of 
plasminogen. 
Pituitary cultures were maintained in media supplemented 
either with regular serum or with serum depleted of plasmin- 
ogen. After suitable labeling with  [35S]methionine,  the cells 
and medium were analysed separately and the immunoreac- 
tive ACTH molecules were harvested by precipitation and 
analysed by SDS PAGE. As seen in Fig. 6, cell extracts from 
cultures  maintained  in  plasminogen  depleted  media  con- 
rained all four species  of ACTH molecules (31,000,  23,000, 
13,000,  and 4,500 mol wt),  whereas only the two largest-- 
31,000 and 23,000 mol wt--were present in the extracellular 
phase. Cultures maintained in plasminogen containing serum 
gave an identical pattern for the intracellular hormone. How- 
ever, in the culture medium there was a substantial reduction 
of the  large  ACTH species--31,000 and  23,000  mol wt-- 
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FIGURE  6  Conditioned  medium  and  cell  extracts  from  anterior 
lobe cultures: immunoprecipitation of corticotropin. Anterior lobe 
cells were plated at a density of 1 x  106 cells per well and incubated 
for  48  h  in  medium  supplemented  with  5%  of  either  native  or 
plasminogen depleted fetal bovine serum. The cultures were then 
labeled for  10  h  in  medium containing [3SS]methionine (200 #Ci/ 
ml).  The conditioned media and cell extracts were incubated with 
antiserum to ACTH and the immunoprecipitates analyzed on SDS 
polyacrylamide gels.  After  the  completion  of electrophoresis the 
individual gel lanes were sliced and the slices assayed for radioac- 
tivity.  (A)  Immunoreactive  corticotropin  molecules  precipitated 
from conditioned medium of cultures incubated with native (O) or 
plasminogen depleted (@) fetal bovine serum.  (B) Immunoreactive 
corticotropin molecules precipitated from  cell extracts of cultures 
incubated with native (O) or plasminogen depleted (@) fetal bovine 
serum. Molecular weights (x 10  -3) in top of A. 
accompanied by an increase in the fraction of smaller mole- 
cules at 13,000 and 4,500 mol wt. 
Comparable experiments performed with a mouse pituitary 
tumor cell line gave identical results for extracellular hormone 
(not shown)--namely, that in the absence of plasminogen, 
only the  31,000-  and  23,000-mol-wt forms were routinely 
detectable. 
Direct evidence that plasmin, generated in the extracellular 
medium, was capable of converting the precursor molecules 
to mature, small ACTH-Iike species was obtained from the 
experiment whose results are summarized in Table II. Here, 
anterior pituitary cultures were first labeled by incubation 
with  [3SS]methionine  in  the  absence  of plasminogen.  The 
isolated conditioned media were supplemented with 50 ~g/ 
ml plasminogen and then incubated further and the ratio of 
radioactivity in the residual ACTH precursor molecules to 
that in small ACTH products was determined after different 
times of incubation: the precursor compartment decreased 
and radioactivity in ACTH accumulated progressively as a 
function of time, the ratio changing by a factor of 4.7.  The 
high recovery of the total radioactivity in the two compart- 
ments->90% in every case--is noteworthy. It is clear from 
the time course of the reaction that the conversion to ACTH 
slows considerably after 40 min of incubation. It is known 
that plasmin is autolytic, that plasmin attacks plasminogen 
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without activating it, and, in certain systems,  also destroys 
PA by proteolysis (32, 43).  Any of the preceding reactions 
could explain the apparent slowing of the reaction, as could 
the reduction in precursor concentration resulting from the 
observed conversion, but we have so far not performed any 
experiments to explore which of these or other alternative 
mechanisms might be operating. 
PA Production by Intermediate Lobe 
It is  known that the  intermediate lobe synthesizes large 
ACTH precursors and their partial degradation products-- 
4,500-mol-wt ACTH, and #-lipotropin and a-MSH. Hence, 
if anterior lobe PA synthesis bore some physiological relation- 
ship to ACTH production, the intermediate lobe might also 
be expected to form PA.  To explore PA production by the 
intermediate lobe, explants of the portion of the gland were 
cultured in wells coated with ~25I-fibrin and the rate of plas- 
minogen-dependent solubilization of radioactivity was meas- 
ured. The results in Fig. 7A show that the intermediate lobes 
produced significant amounts of PA. As in the anterior lobe, 
both  forms  of PA  were produced (Fig.  2A),  and  enzyme 
synthesis was both strongly repressed by hydrocortisone and 
stimulated by dbeAMP.  Because the  intermediate lobe of 
lower vertebrates is subject to dopaminergic neural control 
(21),  we also  tested the  effect of the  dopamine antagonist 
apomorphine; this agent also strongly inhibited intermediate 
lobe enzyme production (Fig.  7B) and it is of interest that 
apomorphine did  not affect PA  synthesis in  anterior lobe 
cultures. This differential response to apomorphine provides 
good incidental evidence for the absence of cross contamina- 
tion of anterior and intermediate lobe cultures, respectively. 
DISCUSSION 
The presence of PA in pituitary tissue was previously reported 
by Astrup (2), who assigned  the enzyme exclusively to the 
vascular endothelium. Without excluding some, presumably 
minor, contributions from the endothelium, our results leave 
no doubt that PA is produced by the glandular cells of both 
the anterior and intermediate lobes. Further, PA synthesis in 
pituitary  tissue  is  modulated  in  response  to  a  variety of 
physiological stimuli just  as  it  is  in  most  normal  tissues, 
including other endocrines. 
Anterior lobe PA activity reflects the secretion of the two 
plasminogen activating enzymes, namely, urokinase and the 
TABLE  II 
Effect of Plasminogen on the Processing of ACTH Precursor 
Time  0  10'  20'  40'  60' 
%  Precursor  81  73  69  61  58 
% ACTH  10  19  21  31  34 
Ratio:Precursor/Product  8.1  3.8  3.3  1.96  1.70 
Anterior lobe cells were plated at a density of 1 x  106 cells/ml and incubated 
for  48  h  in  medium  supplemented  with  5%  plasminogen-depleted fetal 
bovine  serum. The cultures  were  then  washed and  labeled for  10  h  in 
medium containing  [3SS]methionine (200 ~.Ci/ml). The conditioned  media 
were collected, freed of cells, and aliquots were then incubated at 37°C for 
different times with  50 #g/ml plasminogen. Samples were immunoprecipi- 
tated with an ACTH antiserum and the immunoprecipitates analysed on SDS 
PAGE. The individual gel lanes were sliced and the slices assayed  for radio- 
activity.  Results are expressed as percentage of the total  radioactivity  re- 
covered in the respective ACTH components in each gel lane (~9,000 cpm 
were applied to each lane). The ACTH precursor is here defined as the total 
of the 30,000- and 23,000-mol-wt components, while ACTH represents the 
total in the 13,000- and 4,500-mol-wt species. 2oo~ 
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FIGURE  7  Plasminogen activator production in organ cultures of pituitary intermediate lobes. Intermediate lobes, carefully freed 
of anterior and posterior lobe tissue, were sectioned longitudinally and applied to a circle of lens paper that was floated on the 
surface of 300 #1 of medium in a well of a Linbro multiwell plate. After 24 h of incubation the explants were transferred to a 
second well that was coated with ~251-fibrin and contained 300 #1 of medium supplemented with 10 #g/ml highly purified human 
plasminogen in addition to the effectors to be tested. Aliquots of medium were removed at the indicated times and assayed for 
solubilized radioactivity. Four separate explants were exposed to each treatment in parallel and the results averaged. The protein 
content of each group of four explants was determined and the amount of fibrin degraded at each time point is expressed as a 
percentage of the total fibrin originally present in the well. Similar experiments were performed on four separate occasions, and 
the results in all cases were qualitatively identical with those presented in the figure. (A) Effects  of hydrocortisone and dbcAMP. 
4), control, no addition; &, dbcAMP,  10  -3 M; II, hydrocortisone 10  -7 M. (B) O, control, no addition; A, apomorphine 10  -6 M; II, 
apomorphine 10  -s M. 
so-called tissue activator, and the synthesis of both forms is 
modulated  in  response  to  stimuli  that  can  be  considered 
physiological. Since most PA-producing cells are in fact se- 
creting both enzymes concurrently, it is noteworthy that their 
secretion rates can be modulated differentially in response to 
at least one effector, hydrocortisone. 
Although the available data are insufficient to permit any 
precise interpretations, the patterns of pituitary PA modula- 
tion by hormones raise many intriguing questions that provide 
targets for future work. For example, the large increase in PA 
production induced by increased cAMP levels is unlikely to 
be mediated by the response of a single cell type. If that is so, 
it implies that at least several pituitary cell types are probably 
targets for polypeptide or other hormones that activate adenyl 
cyclase. The results obtained to date already exclude posterior 
pituitary hormones,  epinephrine and  at least two releasing 
factors as candidates for this role, and the identification of 
the putative hormones thus presents a challenge for the future. 
Further, the inhibition of PA production by hydrocortisone, 
both alone and in combination with testosterone,  must in- 
volve many, and perhaps all cell types of the anterior lobe. 
This would suggest that the spectrum of anterior lobe func- 
tions  which  can  be  modulated  by  these  steroids  may  be 
broader than could be deduced using physiological evidence 
obtained from intact animals. Pituitary cell cultures exposed 
to various hormone treatments and analysed by the combi- 
nation of immunofluorescence and lytic zone techniques as 
described above can be used as a convenient assay-system for 
testing these and other hypotheses, because they permit each 
subpopulation to be assayed for changes in PA production, if 
a suitably specific antiserum is available for the hormone in 
question. 
One result that deserves comment is the finding (Table I) 
that only a fraction of each hormone-specific cell population 
also produced PA; for the three hormones studied the pro- 
portion of PA-positive cells ranging from 35%  for prolactin 
and LH to  18% for ACTH. We suggest that, at least under 
conditions of submaximal stimulation, the cells of each hor- 
mone-specific population  may be physiologically heteroge- 
neous  with  respect to  the  rate  of hormone  synthesis  and 
secretion. This is analogous with the thyroid where it is well 
established from pulse-labeling data that only a minor fraction 
of the follicular cells in euthyroid glands is active in hormone 
synthesis at any instant (20). To explain our observations on 
pituitary cultures, we propose a working hypothesis that em- 
bodies  some  features  of hormone  synthesis  found  in  the 
thyroid  and  in  pancreatic islets:  we  suggest that  the  three 
pituitary cell types we studied are functioning under condi- 
tions of submaximal stimulation and that each can be imag- 
ined to consist of two subpopulations, a "active" fraction in 
which  peptide products are  directed  along a  pathway that 
leads to secretion, and an "idling" fraction in which newly 
formed peptides are being channelled to intracellular sites for 
storage and degradation. Since the effects of cAMP and hy- 
drocortisone on pituitary PA and hormone synthesis (1,  10, 
31) are qualitatively identical,  we suggest that PA and hor- 
mone secretion occur in parallel, just as they do in pancreatic 
islets exposed to glucose (46);  we therefore propose that PA 
production is a property of the "active" cell population, and 
that  it  can  serve as  an  indirect  measure on  a  marker for 
hormone secretion. 
If the  endocrine  cells  do  indeed  exist  as  "active"  and 
"idling" subpopulations, both of which are synthesizing hor- 
mone precursors, there would seem to be two possible mech- 
anisms  for managing the  intracellular  traffic  of hormone- 
related products: in the first, the peptides would be directed 
to an organelle, such as a secretion granule, where they could 
be held in reserve until mobilized in response to a secretory 
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documented, having been demonstrated in the exocrine pan- 
creas (39). If this type of pathway predominated in the proc- 
essing of pituitary peptides,  the profile of secreted, extracel- 
lular hormonal peptides would necessarily be identical with, 
or closely resemble, those in the main intracellular pool(s). 
Some of our results are not consistent with the pancreatic 
exocrine model and suggest a possible alternative. Specifically, 
the  profiles  of ACTH-related  molecules  in  the  intra-  and 
extracellular compartments were different when pituitary cul- 
tures were labeled in the absence of plasminogen (Fig.  6): the 
smaller,  mature  species--4,500  and  13,000--mol  wt  were 
present within the cells (presumably the "idling"  fraction), 
but,  in plasminogen-free media,  only the large forms were 
extracellular. This result indicates that the extracellular mol- 
ecules could not have been drawn from the same pool as the 
bulk ofintracellular species; they must therefore have followed 
a pathway to secretion that by-passed the intracellular sites 
where the  small  ACTH  peptides  are produced and  stored. 
With  these  data  in  mind,  we  suggest  that  newly  formed 
hormone precursors can be directed along one of two intra- 
cellular pathways, the first leading directly to secretion, and 
the second leading to intracellular sites of storage and degra- 
dation. Our results do not exclude the possibility that some 
of the  latter  pool  could  be  secreted  in  response  to  hyper- 
stimulation. A similar model has been suggested by the data 
of Track  et  al.  (42)  to  account  for  the  hormone labeling 
patterns  he  observed  in  pancreatic  islets.  Our  hypotheses, 
while consistent with all of our data,  should be regarded as 
tentative; they also suggest a variety of experimental tests that 
will be the subject of future work. 
What is the role of PA secretion in the pituitary? Our data 
are still insufficient to support any firm conclusions. Despite 
these reservations, it is probably significant,  firstly,  that PA 
and ACTH are modulated in parallel in response to increased 
cyclic nucleotide levels and to hydrocortisone, and, secondly, 
that plasmin, generated by the cellular secretion of PA, can 
convert some secreted  "big"  ACTH  to the smaller  13,000- 
and 4,500-mol-wt forms. These findings are consistent with 
the  suggestion  that  some  prohormone conversion  may  be 
catalysed, at least in part, by plasmin, a possibility previously 
envisioned also for the processing of proinsulin by the islets 
of Langerhans (46). In the latter tissue granuli-associated thiol 
proteinases have also been reported to be capable of catalysing 
the  proinsulin-insulin  conversion  (7,  l 1).  In  view  of their 
acidic pH optima it is difficult to exclude the possibility that 
these  enzymes  may  be  of  lysosomal  origin,  and  perhaps 
involved  in  the  metabolic  turnover  of  intraceUular 
(pro)hormone. 
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